3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
9
Carcinoma, Renal Cell
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Kidney Neoplasms
3
Lymphoma
2
Leukemia
2
Skin Neoplasms
1
Sezary Syndrome
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Neoplasms
1
Neoplasm Metastasis
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Leukemia-Lymphoma, Adult T-Cell
1
HTLV-I Infections
1
Glioma
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Squamous Cell
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Tacrolimus
29
fludarabine phosphate
21
Methotrexate
21
Cyclophosphamide
21
Mycophenolic Acid
18
Busulfan
15
Antilymphocyte Serum
14
Whole-Body Irradiation
13
Sirolimus
12
fludarabine
11
Peripheral Blood Stem Cell Transplantation
11
Cyclosporine
9
thymoglobulin
8
Melphalan
8
Hematopoietic Stem Cell Transplantation
6
Granulocyte Colony-Stimulating Factor
6
Filgrastim
6
Rituximab
5
Pentostatin
5
Methylprednisolone
5
Thiotepa
4
Stem Cell Transplantation
4
Radiotherapy
4
Cyclosporins
4
ruxolitinib
3
Vorinostat
3
Transplantation
3
Flow Cytometry
3
Etoposide
3
merphos
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Graft vs Host Disease
×
peginterferon alfa-2b
×
Clear all
No trials found.